{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:15:01Z","timestamp":1783350901665,"version":"3.54.6"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T00:00:00Z","timestamp":1330992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T00:00:00Z","timestamp":1330992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Polymyositis (PM) and dermatomyositis (DM) are chronic inflammatory muscle diseases, in which chemokines are thought to contribute to inflammatory cell migration into muscle. In this study, we retrospectively analyzed the expressions of CX3CL1\/fractalkine and its corresponding receptor, CX3CR1, in muscle and lung with interstitial lung disease (ILD) of PM patients and DM patients, and determined the correlation between serum soluble CX3CL1 level and disease activity.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Expressions of CX3CL1 and CX3CR1 in muscle and lung tissue were analyzed by immunohistochemistry. Serum CX3CL1 concentrations were measured by ELISA. For evaluation of patients' disease activity, serum creatinine kinase, manual muscle testing, and the alveolar-arterial oxygen pressure difference were used independently.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>CX3CL1 was expressed on infiltrated mononuclear cells and endothelial cells in muscle affected by PM and DM and in lung with ILD, whereas CX3CR1 was expressed on some CD4<jats:sup>+<\/jats:sup> T cells, a majority of CD8<jats:sup>+<\/jats:sup> T cells, and most macrophages in muscle, and on infiltrated mononuclear cells in the lung. Serum soluble CX3CL1 was significantly higher in PM patients and DM patients than in healthy controls. The CX3CL1 level was correlated with serum creatinine kinase and manual muscle testing score. In patients with PM and DM with ILD, serum CX3CL1 was also correlated with alveolar-arterial oxygen pressure difference. Furthermore, CX3CL1 was significantly decreased after conventional treatment.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>The interaction between CX3CL1 and CX3CR1 might contribute to the inflammatory cell infiltration into affected muscle and lung with ILD in PM patients and DM patients. Serum CX3CL1 level could be a surrogate marker of disease activity.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar3761","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T11:14:12Z","timestamp":1331032452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Serum level of soluble CX3CL1\/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity"],"prefix":"10.1186","volume":"14","author":[{"given":"Fumihito","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinya","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Ebisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsei","family":"Hirohata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Mizusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Miyasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Nanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,6]]},"reference":[{"key":"3529_CR1","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC: Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med. 1991, 325: 1487-1498.","journal-title":"N Engl J Med"},{"key":"3529_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/00005072-199603000-00009","volume":"55","author":"DS Tews","year":"1996","unstructured":"Tews DS, Goebel HH: Cytokine expression profile in idiopathic inflammatory myopathies. J Neuropathol Exp Neurol. 1996, 55: 342-347. 10.1097\/00005072-199603000-00009.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3529_CR3","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1172\/JCI118749","volume":"97","author":"N Goebels","year":"1996","unstructured":"Goebels N, Michaelis D, Engelhardt M, Huber S, Bender A, Pongratz D, Johnson MA, Wekerle H, Tschopp J, Jenne D, Hohlfeld R: Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest. 1996, 97: 2905-2910. 10.1172\/JCI118749.","journal-title":"J Clin Invest"},{"key":"3529_CR4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/art.10794","volume":"47","author":"I Marie","year":"2002","unstructured":"Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot MF, Devulder B, Herson S, Levesque H, Courtois H: Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum. 2002, 47: 614-622. 10.1002\/art.10794.","journal-title":"Arthritis Rheum"},{"key":"3529_CR5","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","volume":"164","author":"WW Douglas","year":"2001","unstructured":"Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR, Ryu JH: Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med. 2001, 164: 1182-1185.","journal-title":"Am J Respir Crit Care Med"},{"key":"3529_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","volume":"56","author":"A Bohan","year":"1977","unstructured":"Bohan A, Peter JB, Bowman RL, Pearson CM: Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore). 1977, 56: 255-286.","journal-title":"Medicine (Baltimore)"},{"key":"3529_CR7","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1002\/art.23963","volume":"58","author":"SM Sultan","year":"2008","unstructured":"Sultan SM, Allen E, Oddis CV, Kiely P, Cooper RG, Lundberg IE, Vencovsky J, Isenberg DA: Reliability and validity of the myositis disease activity assessment tool. Arthritis Rheum. 2008, 58: 3593-3599. 10.1002\/art.23963.","journal-title":"Arthritis Rheum"},{"key":"3529_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJM199802123380706","volume":"338","author":"AD Luster","year":"1998","unstructured":"Luster AD: Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med. 1998, 338: 436-445. 10.1056\/NEJM199802123380706.","journal-title":"N Engl J Med"},{"key":"3529_CR9","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/385640a0","volume":"385","author":"JF Bazan","year":"1997","unstructured":"Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ: A new class of membrane-bound chemokine with a CX3C motif. Nature. 1997, 385: 640-644. 10.1038\/385640a0.","journal-title":"Nature"},{"key":"3529_CR10","doi-asserted-by":"publisher","first-page":"44622","DOI":"10.1074\/jbc.M107327200","volume":"276","author":"CL Tsou","year":"2001","unstructured":"Tsou CL, Haskell CA, Charo IF: Tumor necrosis factor-alpha-converting enzyme mediates the inducible cleavage of fractalkine. J Biol Chem. 2001, 276: 44622-44626. 10.1074\/jbc.M107327200.","journal-title":"J Biol Chem"},{"key":"3529_CR11","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1084\/jem.188.8.1413","volume":"188","author":"AM Fong","year":"1998","unstructured":"Fong AM, Robinson LA, Steeber DA, Tedder TF, Yoshie O, Imai T, Patel DD: Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med. 1998, 188: 1413-1419. 10.1084\/jem.188.8.1413.","journal-title":"J Exp Med"},{"key":"3529_CR12","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1002\/art.10622","volume":"46","author":"T Nanki","year":"2002","unstructured":"Nanki T, Imai T, Nagasaka K, Urasaki Y, Nonomura Y, Taniguchi K, Hayashida K, Hasegawa J, Yoshie O, Miyasaka N: Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis. Arthritis Rheum. 2002, 46: 2878-2883. 10.1002\/art.10622.","journal-title":"Arthritis Rheum"},{"key":"3529_CR13","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.4049\/jimmunol.168.12.6173","volume":"168","author":"M Nishimura","year":"2002","unstructured":"Nishimura M, Umehara H, Nakayama T, Yoneda O, Hieshima K, Kakizaki M, Dohmae N, Yoshie O, Imai T: Dual functions of fractalkine\/CX3C ligand 1 in trafficking of perforin+\/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol. 2002, 168: 6173-6180.","journal-title":"J Immunol"},{"key":"3529_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","volume":"91","author":"T Imai","year":"1997","unstructured":"Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ, Yoshie O: Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell. 1997, 91: 521-530. 10.1016\/S0092-8674(00)80438-9.","journal-title":"Cell"},{"key":"3529_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/ar2139","volume":"9","author":"C Grundtman","year":"2007","unstructured":"Grundtman C, Malmstrom V, Lundberg IE: Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies. Arthritis Res Ther. 2007, 9: 208-10.1186\/ar2139.","journal-title":"Arthritis Res Ther"},{"key":"3529_CR16","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.4049\/jimmunol.175.10.6987","volume":"175","author":"F Suzuki","year":"2005","unstructured":"Suzuki F, Nanki T, Imai T, Kikuchi H, Hirohata S, Kohsaka H, Miyasaka N: Inhibition of CX3CL1 (fractalkine) improves experimental autoimmune myositis in SJL\/J mice. J Immunol. 2005, 175: 6987-6996.","journal-title":"J Immunol"},{"key":"3529_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975, 292: 344-347. 10.1056\/NEJM197502132920706.","journal-title":"N Engl J Med"},{"key":"3529_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB: Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975, 292: 403-407. 10.1056\/NEJM197502202920807.","journal-title":"N Engl J Med"},{"key":"3529_CR19","volume-title":"Aids to the Examination of the Peripheral Nervous System","author":"Medical Research Council","year":"1981","unstructured":"Medical Research Council: Aids to the Examination of the Peripheral Nervous System. 1981, Memorandum no. 45. London: Her Majesty's Stationery Office"},{"key":"3529_CR20","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/art.21140","volume":"52","author":"H Sawai","year":"2005","unstructured":"Sawai H, Park YW, Roberson J, Imai T, Goronzy JJ, Weyand CM: T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis. Arthritis Rheum. 2005, 52: 1392-1401. 10.1002\/art.21140.","journal-title":"Arthritis Rheum"},{"key":"3529_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20035","volume":"62","author":"LG Rider","year":"2010","unstructured":"Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K, Feldman BM, Wright SJ, Lindsley CB, Pachman LM, Villalba ML, Lovell DJ, Bowyer SL, Plotz PH, Miller FW, Hicks JE: Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken). 2010, 62: 465-472. 10.1002\/acr.20035.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3529_CR22","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/rheumatology\/40.11.1262","volume":"40","author":"FW Miller","year":"2001","unstructured":"Miller FW, Rider LG, Chung YL, Cooper R, Danko K, Farewell V, Lundberg I, Morrison C, Oakley L, Oakley I, Pilkington C, Vencovsky J, Vincent K, Scott DL, Isenberg DA: Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford). 2001, 40: 1262-1273. 10.1093\/rheumatology\/40.11.1262.","journal-title":"Rheumatology (Oxford)"},{"key":"3529_CR23","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.4049\/jimmunol.0903212","volume":"184","author":"T Matsumiya","year":"2010","unstructured":"Matsumiya T, Ota K, Imaizumi T, Yoshida H, Kimura H, Satoh K: Characterization of synergistic induction of CX3CL1\/fractalkine by TNF-alpha and IFN-gamma in vascular endothelial cells: an essential role for TNF-alpha in post-transcriptional regulation of CX3CL1. J Immunol. 2010, 184: 4205-4214. 10.4049\/jimmunol.0903212.","journal-title":"J Immunol"},{"key":"3529_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jdermsci.2010.07.012","volume":"60","author":"T Kawashima","year":"2010","unstructured":"Kawashima T, Tada Y, Asano Y, Yazawa N, Tomita M, Tamaki Z, Kubo M, Ihn H, Sugaya M, Kadono T, Tamaki K, Sato S: Serum TARC\/CCL17 levels are increased in dermatomyositis associated with interstitial lung disease. J Dermatol Sci. 2010, 60: 52-54. 10.1016\/j.jdermsci.2010.07.012.","journal-title":"J Dermatol Sci"},{"key":"3529_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","volume":"13","author":"EC Baechler","year":"2007","unstructured":"Baechler EC, Bauer JW, Slattery CA, Ortmann WA, Espe KJ, Novitzke J, Ytterberg SR, Gregersen PK, Behrens TW, Reed AM: An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol Med. 2007, 13: 59-68.","journal-title":"Mol Med"},{"key":"3529_CR26","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1002\/art.24936","volume":"60","author":"H Bilgic","year":"2009","unstructured":"Bilgic H, Ytterberg SR, Amin S, McNallan KT, Wilson JC, Koeuth T, Ellingson S, Newman B, Bauer JW, Peterson EJ, Baechler EC, Reed AM: Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis. Arthritis Rheum. 2009, 60: 3436-3446. 10.1002\/art.24936.","journal-title":"Arthritis Rheum"},{"key":"3529_CR27","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/rheumatology\/keq196","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono T, Kawaguchi Y, Sugiura T, Ichida H, Takagi K, Katsumata Y, Hanaoka M, Okamoto Y, Ota Y, Yamanaka H: Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease. Rheumatology (Oxford). 2010, 49: 1878-1881. 10.1093\/rheumatology\/keq196.","journal-title":"Rheumatology (Oxford)"},{"key":"3529_CR28","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jaci.2003.09.041","volume":"112","author":"AC Rimaniol","year":"2003","unstructured":"Rimaniol AC, Till SJ, Garcia G, Capel F, Godot V, Balabanian K, Durand-Gasselin I, Varga EM, Simonneau G, Emilie D, Durham SR, Humbert M: The CX3C chemokine fractalkine in allergic asthma and rhinitis. J Allergy Clin Immunol. 2003, 112: 1139-1146. 10.1016\/j.jaci.2003.09.041.","journal-title":"J Allergy Clin Immunol"},{"key":"3529_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/ard.2003.018705","volume":"64","author":"M Hasegawa","year":"2005","unstructured":"Hasegawa M, Sato S, Echigo T, Hamaguchi Y, Yasui M, Takehara K: Up regulated expression of fractalkine\/CX3CL1 and CX3CR1 in patients with systemic sclerosis. Ann Rheum Dis. 2005, 64: 21-28. 10.1136\/ard.2003.018705.","journal-title":"Ann Rheum Dis"},{"key":"3529_CR30","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1002\/art.22208","volume":"54","author":"M Matsunawa","year":"2006","unstructured":"Matsunawa M, Isozaki T, Odai T, Yajima N, Takeuchi HT, Negishi M, Ide H, Adachi M, Kasama T: Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis. Arthritis Rheum. 2006, 54: 3408-3416. 10.1002\/art.22208.","journal-title":"Arthritis Rheum"},{"key":"3529_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","volume":"43","author":"DA Isenberg","year":"2004","unstructured":"Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, Oddis C, Pilkington C, Plotz P, Scott D, Vencovsky J, Cooper R, Rider L, Miller F: International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford). 2004, 43: 49-54. 10.1093\/rheumatology\/keg427.","journal-title":"Rheumatology (Oxford)"},{"key":"3529_CR32","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1002\/art.20349","volume":"50","author":"LG Rider","year":"2004","unstructured":"Rider LG, Giannini EH, Brunner HI, Ruperto N, James-Newton L, Reed AM, Lachenbruch PA, Miller FW: International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum. 2004, 50: 2281-2290. 10.1002\/art.20349.","journal-title":"Arthritis Rheum"},{"key":"3529_CR33","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1002\/art.21291","volume":"52","author":"CV Oddis","year":"2005","unstructured":"Oddis CV, Rider LG, Reed AM, Ruperto N, Brunner HI, Koneru B, Feldman BM, Giannini EH, Miller FW: International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum. 2005, 52: 2607-2615. 10.1002\/art.21291.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3761.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3761\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3761.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:29:51Z","timestamp":1728383391000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,6]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,4]]}},"alternative-id":["3529"],"URL":"https:\/\/doi.org\/10.1186\/ar3761","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,6]]},"assertion":[{"value":"30 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R48"}}